BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36507718)

  • 1. Addressing statistical issues when leveraging external control data in pediatric clinical trials using Bayesian dynamic borrowing.
    Spanakis E; Kron M; Bereswill M; Mukhopadhyay S
    J Biopharm Stat; 2023 Nov; 33(6):752-769. PubMed ID: 36507718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging historical data into oncology development programs: Two case studies of phase 2 Bayesian augmented control trial designs.
    Smith CL; Thomas Z; Enas N; Thorn K; Lahn M; Benhadji K; Cleverly A
    Pharm Stat; 2020 May; 19(3):276-290. PubMed ID: 31903699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
    Hupf B; Bunn V; Lin J; Dong C
    Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trials.
    Kopp-Schneider A; Wiesenfarth M; Held L; Calderazzo S
    Pharm Stat; 2024; 23(1):4-19. PubMed ID: 37632266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian Design for Pediatric Clinical Trials with Binary Endpoints When Borrowing Historical Information of Treatment Effect.
    Jin M; Li Q; Kaur A
    Ther Innov Regul Sci; 2021 Mar; 55(2):360-369. PubMed ID: 32955713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian Dynamic Borrowing of Historical Information with Applications to the Analysis of Large-Scale Assessments.
    Kaplan D; Chen J; Yavuz S; Lyu W
    Psychometrika; 2023 Mar; 88(1):1-30. PubMed ID: 35687222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bayesian basket trial design using a calibrated Bayesian hierarchical model.
    Chu Y; Yuan Y
    Clin Trials; 2018 Apr; 15(2):149-158. PubMed ID: 29499621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials.
    Su L; Chen X; Zhang J; Yan F
    JCO Precis Oncol; 2022 Mar; 6():e2100394. PubMed ID: 35263169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of propensity score-based Bayesian borrowing of external adult data in pediatric trials: A pragmatic evaluation through a case study in acute lymphoblastic leukemia (ALL).
    Majumdar A; Rothwell R; Reaman G; Ahlberg C; Roy P
    J Biopharm Stat; 2023 Nov; 33(6):737-751. PubMed ID: 36600441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A frequentist approach to dynamic borrowing.
    Li R; Lin R; Huang J; Tian L; Zhu J
    Biom J; 2023 Oct; 65(7):e2100406. PubMed ID: 37189217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical profile Bayesian estimation for extrapolation of historical adult data to pediatric drug development.
    Wu Y; Hui J; Deng Q
    Pharm Stat; 2020 Nov; 19(6):787-802. PubMed ID: 32573051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covariate handling approaches in combination with dynamic borrowing for hybrid control studies.
    Fu C; Pang H; Zhou S; Zhu J
    Pharm Stat; 2023; 22(4):619-632. PubMed ID: 36882191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian Method of Borrowing Study-Level Historical Longitudinal Control Data for Mixed-Effects Models with Repeated Measures.
    Li H; Jin M; Chung YC; Zhong S; Wang L
    Ther Innov Regul Sci; 2023 Jan; 57(1):142-151. PubMed ID: 36315398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alone, together: On the benefits of Bayesian borrowing in a meta-analytic setting.
    Harari O; Soltanifar M; Verhoek A; Heeg B
    Pharm Stat; 2023; 22(5):903-920. PubMed ID: 37321565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BEATS: Bayesian hybrid design with flexible sample size adaptation for time-to-event endpoints.
    Bi D; Liu M; Lin J; Liu R
    Stat Med; 2023 Dec; 42(30):5708-5722. PubMed ID: 37858287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study.
    Wang X; Suttner L; Jemielita T; Li X
    J Biopharm Stat; 2022 Jan; 32(1):170-190. PubMed ID: 34939894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elastic priors to dynamically borrow information from historical data in clinical trials.
    Jiang L; Nie L; Yuan Y
    Biometrics; 2023 Mar; 79(1):49-60. PubMed ID: 34437714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian hypothesis testing with frequentist characteristics in clinical trials.
    Quan H; Zhang B; Lan Y; Luo X; Chen X
    Contemp Clin Trials; 2019 Dec; 87():105858. PubMed ID: 31669448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
    Harun N; Liu C; Kim MO
    Pharm Stat; 2020 Sep; 19(5):613-625. PubMed ID: 32185886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dynamic power prior for borrowing historical data in noninferiority trials with binary endpoint.
    Liu GF
    Pharm Stat; 2018 Feb; 17(1):61-73. PubMed ID: 29125220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.